AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

CCTC Preview Videos



Free access to many more videos such as these is available with your Clinical Chemistry Trainee Council registration. Register today.

Interpretation of Epidemiologic Studies: Association vs. Causation

NOV.11.2020 | Julie E. Buring
Dr. Buring outlines the important differences between Association and Causation in the interpretation of epidemiologic studies.




Randomized Controlled Trials

NOV.17.2020 | Julie E. Buring
Dr. Buring delineates the different types of Randomized Control Trials and their best uses.




Principles of Study Design and Analysis: Cohort Studies

NOV.11.2020 | Julie E. Buring
Dr. Buring delineates the different types of Randomized Control Trials and their best uses.




Principles of Study Design and Analysis: Case-Control Studies

NOV.24.2020 | Julie E. Buring
Dr. Buring discusses the principles of study design and analysis for case-control studies, cohort studies, and randomized clinical trials.




SPECIAL ISSUES: Confounding and Effect Modification

DEC.15.2020 | Julie E. Buring
Dr. Buring goes into detail about the special issue of confounding in epidemiologic studies, and also a complementary but different issue called effect modification.




SPECIAL ISSUES: P-values and Confidence Intervals; Power and Sample Size

DEC.8.2020 | Julie E. Buring
Dr. Buring discusses the special issue of chance as an explanation of findings in epidemiologic studies, and in particular about p-Values versus Confidence Intervals and the issue of power related sample size.




Sceening for Early Disease Detection: Not as simple as it seems

DEC.22.2020 | Julie E. Buring
Dr. Buring weighs in on the pros and cons of screening for early disease detection, as well as important considerations when looking at disease screening data.